A Programmed Cell‐Mimicking Nanoparticle Driven by Potato Alkaloid for Targeted Cancer Chemoimmunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Programmed Cell‐Mimicking Nanoparticle Driven by Potato Alkaloid for Targeted Cancer Chemoimmunotherapy

Published:2021-05-08 Issue:13 Volume:10 Page:2100311
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Li Jie¹,Tang Wei¹,Yang Yi¹,Shen Qing²³,Yu Yang¹,Wang Xiaoyou¹,Fu Yu¹,Li Chong¹^ORCID

Affiliation:

1. Medical Research Institute College of Pharmaceutical Sciences Southwest University Chongqing 400715 China

2. Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph Shanghai 200336 China

3. YITU AI Research Institute for Healthcare Hangzhou Zhejiang 310000 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202100311

Reference45 articles.

1. Cell membrane-camouflaged nanoparticles for drug delivery

2. Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles

3. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

4. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review: Surface Engineering of Lipid‐Based Drug Delivery Systems;Small;2024-07-14

2. Solamargine improves the therapeutic efficacy of anti-PD-L1 in lung adenocarcinoma by inhibiting STAT1 activation;Phytomedicine;2024-06

3. Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy;Nano Letters;2024-05-21

4. Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation;Advanced Healthcare Materials;2024-05-02

5. Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment;International Journal of Nanomedicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3